Silver Book Fact

Omega-3 polyunsaturated fatty acids have been found to protect against the development and progression of deterioration of the retina (retinopathy).

Connor, Kip M., John P. SanGiovanni, Chatarina Lofqvist, Christopher M. Aderman, Jing Chen, Akiko Higuchi, Song Hong, Elke A. Pravda, Sharon Majchrzak, Deobrah Carper, Ann Hellstrom,Jing X. Kang, Emily Y. Chew, Norman Salem, Charles N. Sherhan, & Lois Smi. Increased Dietary Intake of Omega-3 Polyunsaturated Fatty Acids Reduces Pathological Retinal Angiogenesis. Nature Med. June 2007; 13(7): 868-73. http://www.nature.com/nm/journal/v13/n7/abs/nm1591.html

Reference

Title
Increased Dietary Intake of Omega-3 Polyunsaturated Fatty Acids Reduces Pathological Retinal Angiogenesis
Publication
Nature Med
Publication Date
June 2007
Authors
Connor, Kip M., John P. SanGiovanni, Chatarina Lofqvist, Christopher M. Aderman, Jing Chen, Akiko Higuchi, Song Hong, Elke A. Pravda, Sharon Majchrzak, Deobrah Carper, Ann Hellstrom,Jing X. Kang, Emily Y. Chew, Norman Salem, Charles N. Sherhan, & Lois Smi
Volume & Issue
Volume 13, Issue 7
Pages
868-73
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Gene transfer process treatment for diabetic retinopathy
    A gene transfer process that produces a VEGF receptor prevents retinal vascular permeability (RVP) associated with diabetes that could have value in treating diabetic retinopathy.  
  • Laser Treatment for DR
    Laser treatment of PDR can reduce the 5-year risk of blindness by 90%, and the risk of visual loss from DME by 50%.  
  • AMD risk reduction through diet
    A recent study indicated that 20% of AMD cases in the AREDS study would have been eliminated if the participants consumed diets with a dGI (dietary glycemic index) below the…  
  • After 54 weeks of receiving bevacizumab, wet age-realted macular degeneration (AMD) patients were more likely to gain at least 6 letters of contrast sensitivity than patikents recieving standard care–35.4% versus…  
  • Timely treatment and follow-up care can reduce the risk of blindness in individuals with proliferative retinopathy by 95%.